Predictive value of minimal residual disease measurement during remission in childhood acute lymphoblastic leukemia: The results of the International-BFM Study Group (I-BFM-SG).

被引：0
|
作者：
Biondi, A
VanDongen, JJM
Seriu, T
PanzerGrumayer, ER
Willemse, MJ
Corral, L
Stolz, F
Bartram, CR
机构：
[1] UNIV MILAN,OSPED S GERARDO,PEDIAT CLIN,MONZA,ITALY
[2] ERASMUS UNIV ROTTERDAM,DEPT IMMUNOL,NL-3000 DR ROTTERDAM,NETHERLANDS
[3] RUPRECHT KARLS UNIV KLINIKUM,INST HUMANGENET & ANTHROPOL,HEIDELBERG,GERMANY
[4] ST ANNA CHILDRENS HOSP,CHILDRENS CANC RES INST,A-1090 VIENNA,AUSTRIA
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1878 / 1878
页数：1
相关论文
共 50 条
  • [21] The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG
    Jean-Hugues Dalle
    Adriana Balduzzi
    Peter Bader
    Anna Pieczonka
    Isaac Yaniv
    Arjan Lankester
    Marc Bierings
    Akif Yesilipek
    Petr Sedlacek
    Marianne Ifversen
    Peter Svec
    Jacek Toporski
    Taifun Gungor
    Jacek Wachowiak
    Evgenia Glogova
    Ulrike Poetschger
    Christina Peters
    Bone Marrow Transplantation, 2021, 56 : 257 - 266
  • [22] DETECTION OF MINIMAL RESIDUAL DISEASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED ACCORDING TO THE ALL IC-BFM-2002 PROTOCOL
    Pawinska-Wasikowska, Katarzyna
    Balwierz, Walentyna
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 834 - 834
  • [23] Prognostic impact of minimal residual disease in childhood acute lymphoblastic leukaemia depends on immunological subtype: results of trial AIEOP-BFM ALL 2000
    Schrappe, M.
    Rizzari, C.
    Mann, G.
    Moericke, A.
    Valsecchi, M. G.
    Zimmerman, M.
    Bartram, C. R.
    Panzer-Gruemayer, R.
    Schrauder, A.
    Cazzaniga, G.
    Flohr, T.
    Parasole, R.
    Reiter, A.
    Ludwig, W. D.
    Lo Nigro, L.
    Basso, G.
    de Rossi, G.
    Barisone, E.
    Niggli, F.
    Gadner, H.
    Conter, V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 1 - 1
  • [24] Flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia:: a multi-centric standardization program results of the AIEOP-BFM-ALL-FCM MRD-study group
    Gaipa, G.
    Dworzak, M. N.
    Maglia, O.
    Benetello, A.
    Veltroni, M.
    Ratei, R.
    Schumich, A.
    Poetschger, U.
    Husak, Z.
    Karawajew, L.
    Biondi, A.
    Basso, G.
    CYTOMETRY PART A, 2008, 73A (01) : 81 - 81
  • [25] Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients
    Conter, Valentino
    Valsecchi, Maria Grazia
    Arico, Maurizio
    Rizzari, Carmelo
    Parasole, Rosanna
    Messina, Chiara
    De Rossi, Giulio
    Barisone, Elena
    Lo Nigro, Luca
    Santoro, Nicola
    Ziino, Ottavio
    Locatelli, Franco
    Pession, Andrea
    Testi, Anna Maria
    Micalizzi, Concetta
    Biondi, Andrea
    Basso, Giuseppe
    Silvestri, Daniela
    Masera, Giuseppe
    BLOOD, 2009, 114 (22) : 135 - 135
  • [26] 6-YEAR EXPERIENCE WITH A COMPREHENSIVE APPROACH TO THE TREATMENT OF RECURRENT CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL-REZ BFM 85) - A RELAPSE STUDY OF THE BFM GROUP
    HENZE, G
    FENGLER, R
    HARTMANN, R
    KORNHUBER, B
    JANKASCHAUB, G
    NIETHAMMER, D
    RIEHM, H
    BLOOD, 1991, 78 (05) : 1166 - 1172
  • [27] Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study
    Balduzzi, Adriana
    Dalle, Jean-Hugues
    Lankester, Arjan C.
    Yaniv, Isaac
    Yesilipek, Akif
    Sedlacek, Petr
    Ifversen, Marianne
    Sufliarska, Sabina
    Bierings, Marc B.
    Wachowiak, Jacek
    Toporski, Jacek
    Poetschger, Ulrike
    Glogova, Evgenia
    Hirsch, Ingeborg
    Peters, Christina
    BLOOD, 2015, 126 (23)
  • [28] Minimal residual disease in acute myeloid leukemia in children - standardization and evaluation of immunophenotyping in the AML-BFM-98 study
    Reinhardt, D
    Langebrake, C
    Creutzig, U
    Vormoor, J
    Brune, C
    Thorwesten, M
    Ingiliz, P
    Hrusak, O
    Dworzak, M
    Griesinger, F
    KLINISCHE PADIATRIE, 2002, 214 (04): : 179 - 187
  • [29] Clinical Impact of Additional Cytogenetic Aberrations and Treatment in Pediatric t(8;21)-Positive AML: Results from an International Retrospective I-BFM-SG Study
    Reedijk, Ardine
    Kaspers, Gertjan
    Fiocco, Marta
    Pession, Andrea
    Reinhardt, Dirk
    Zimmermann, Martin
    Dworzak, Michael
    Alonzo, Todd A.
    Johnston, Donna
    Zapotocky, Michal
    De Moerloose, Barbara
    Finita, Fynn
    Lee, Vincent
    Taga, Takashi
    Tawa, Akio
    Auvrignon, Anne
    Zeller, Bernward
    Salgado, Carmen
    Balwierz, Walentyna
    Popa, Alexander
    Rubnitz, Jeffrey
    Beverloo, H. B. Berna
    Harrison, Christine J.
    Gibson, Brenda
    BLOOD, 2012, 120 (21)
  • [30] Impact of Minimal Residual Disease (MRD) Assessed before Transplantation on the Outcome of Children with Acute Myeloid Leukemia Given an Allograft: A Retrospective Study By the I-BFM Study Group
    Pigazzi, Martina
    Benetton, Maddalena
    Walter, Christiane
    Hansen, Maria
    Skou, Anne-Sofie
    Da Ros, Ambra
    Marchetti, Anna
    Polato, Katia
    Belloni, Mattia
    Tregnago, Claudia
    Abrahamsson, Jonas
    Fogelstrand, Linda
    Von Neuhoff, Nils
    Reinhardt, Dirk
    Hasle, Henrik
    Locatelli, Franco
    Merli, Pietro
    BLOOD, 2020, 136
12345